Christine Nobi Paul

Christine Paul practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Christine Paul's NPI, 1568966794, was assigned on March 21, 2018. Christine Paul holds Michigan license 4301507636.

Christine Paul's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Christine Paul's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Christine Paul is also affiliated with Trinity Health Grand Rapids Hospital. The medical group on file is Mary Free Bed Rehabilitation Hospital. Dmand AI also links Christine Paul to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christine Paul practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Christine Paul's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Christine Paul's licenses on file in 2 states: Michigan and Florida.

CMS data shows 372 Medicare services from Christine Paul across 3 procedure codes in 2024, for 123 Medicare patients. Medicare paid $31,129 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Christine Paul in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christine Paul's median patient age at 71, with 43% women.

Christine Paul accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Christine Paul from 6 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $47.